Abstract:Abstract Background Intercellular communication is mediated by extracellular vesicles (EVs), as they enclose selectively packaged biomolecules that can be horizontally transferred from donor to recipient cells. Because all cells constantly generate and recycle EVs, they provide accurate timed snapshots of individual pathophysiological status. Since blood plasma circulates through the whole body, it is often the biofluid of choice for biomarker detection in EVs. Blood collection is easy and minimally invasive, yet reproducible procedures to obtain pure EV samples from circulating biofluids are still lacking. Here, we addressed central aspects of EV immunoaffinity isolation from simple and complex matrices, such as plasma. Methods Cell-generated EV spike-in models were isolated and purified by size-exclusion chromatography, stained with cellular dyes and characterized by nano flow cytometry. Fluorescently-labelled spike-in EVs emerged as reliable, high-throughput and easily measurable readouts, which were employed to optimize our EV immunoprecipitation strategy and evaluate its performance. Plasma-derived EVs were captured and detected using this straightforward protocol, sequentially combining isolation and staining of specific surface markers, such as CD9 or CD41. Multiplexed digital transcript detection data was generated using the Nanostring nCounter platform and evaluated through a dedicated bioinformatics pipeline. Results Beads with covalently-conjugated antibodies on their surface outperformed streptavidin-conjugated beads, coated with biotinylated antibodies, in EV immunoprecipitation. Fluorescent EV spike recovery evidenced that target EV subpopulations can be efficiently retrieved from plasma, and that their enrichment is dependent not only on complex matrix composition, but also on the EV surface phenotype. Finally, mRNA profiling experiments proved that distinct EV subpopulations can be captured by directly targeting different surface markers. Furthermore, EVs isolated with anti-CD61 beads enclosed mRNA expression patterns that might be associated to early-stage lung cancer, in contrast with EVs captured through CD9, CD63 or CD81. The differential clinical value carried within each distinct EV subset highlights the advantages of selective isolation. Conclusions This EV isolation protocol facilitated the extraction of clinically useful information from plasma. Compatible with common downstream analytics, it is a readily implementable research tool, tailored to provide a truly translational solution in routine clinical workflows, fostering the inclusion of EVs in novel liquid biopsy settings.

Sequential separation and profiling of extracellular vesicles using antibody-aptamer conjugates

Sequencing-Based Protein Analysis of Single Extracellular Vesicles.

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Immobilization coupling with aptamer assisted dual cycle amplification for sensitive sEVs isolation and analysis

Multiplex protein profiling method for extracellular vesicle protein detection

Micro size exclusion chromatography combined with a multiplex protein profiling method for extracellular vesicle protein detection from small sample volumes

High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis

Single Extracellular Vesicle Protein Analysis Using Immuno‐Droplet Digital Polymerase Chain Reaction Amplification

Aptamer‐based extracellular vesicle isolation, analysis and therapeutics

Development of complementary analytical methods to characterize extracellular vesicles

Affinity-based isolation of extracellular vesicles by means of single-domain antibodies bound to macroporous methacrylate-based copolymer

High-throughput, multiplexed quantification, and sorting of single EVs at single-molecule level

Droplet microfluidic platform for extracellular vesicle isolation based on magnetic bead handling

Peptide-based capture-and-release purification of extracellular vesicles and statistical algorithm enabled quality assessment

Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h

Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies

Isolation of anti-extra-cellular vesicle single-domain antibodies by direct panning on vesicle-enriched fractions

High-Efficiency Capture and Proteomic Analysis of Plasma-Derived Extracellular Vesicles through Affinity Purification

High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array

An aptamer‐guided fluorescence polarisation platform for extracellular vesicle liquid biopsy

Extracellular vesicles selective capture by peptide-functionalized hollow fiber membranes